Sort
15,842 grants matching “pancreatic cancer”
CORE--TISSUE RESEARCH AND PATHOLGOGY SERVICES
$215,396Rajiv Dhir · University Of Pittsburgh At Pittsburgh · P30 · FY2008 · CA
ADAM8 Is a Novel Target for Treatment of Triple-Negative Breast Cancer
$215,325Gail E Sonenshein · Tufts University Boston · R21 · FY2016 · CA
Molecular Studies on MUC4 Mucin Gene
$215,318Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2006 · CA
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI)
$215,309University Of Connecticut Sch Of Med/Dnt · R01 · FY2001 · CA
Core B: Liver Metastasis Resource Core (LMRC)
$215,306Edwin Melencio Posadas · Cedars-Sinai Medical Center · P01 · FY2024 · CA
Discovery of PPI inhibitors for the FAK FAT domain
$215,284Timothy A Marlowe · University Of Arizona · R21 · FY2023 · CA
Targeting Pancreatic Cancer with Novel Mnk-eIF4E and AR Modulating Agents
$215,284Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R21 · FY2015 · CA
DNA methylation, Liquid Biopsy, and Pancreatic Cancer
$215,284Mark A Nelson · University Of Arizona · R21 · FY2022 · CA
Mechanism of RelA activation in Pancreatic cancer
$215,175University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Mechanism of RelA activation in Pancreatic cancer
$215,175University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
Mechanism of RelA activation in Pancreatic cancer
$215,175University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
Systemic Nanocurcumin for Pancreatic Cancer Therapy
$215,171Anirban Maitra · Johns Hopkins University · U54 · FY2010 · CA
Multiscale Computational Oncology Research Core
$215,170Elana Fertig · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Molecular Mechanisms of Programmed Necrosis Execution
$215,117Ayaz Najafov · Ut Southwestern Medical Center · R35 · FY2024 · GM
Core C: Computational Core
$215,102Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · P01 · FY2018 · CA
Core A: Administrative Core
$215,097William G Hawkins · Washington University · P50 · FY2025 · CA
Clinical protocols for the treatment of gastrointestinal cancer
$215,076Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
IN VIVO MEASUREMENT OF ONCOGENIC KRAS-DEPENDENT GLUCOSE METABOLISM IN MOUSE MODELS OF PANCREATIC CANCER
$215,054Dana-Farber Cancer Institute, Inc. · · FY2012 · Department of Defense
Core C: Animal Modeling and Imaging
$215,040Scott Keith Lyons · Cold Spring Harbor Laboratory · P01 · FY2025 · CA
Core C: Animal Modeling and Imaging
$215,040Mikala Egeblad · Cold Spring Harbor Laboratory · P01 · FY2023 · CA
Cancer Biology Training Program
$214,959Jennifer D Black · University Of Nebraska Medical Center · T32 · FY2022 · CA
Engineering Siglec15/TGF-beta targeted bispecific antibodies that modulate the tumor microenvironment and enhances T-cell immunotherapy against pancreatic cancer
$214,931Samuel Lai · Univ Of North Carolina Chapel Hill · R21 · FY2023 · CA
Inhibition of Recombination DNA Repair in Pancreatic Cancer Cells
$214,900Philip Paul Connell · University Of Chicago · R21 · FY2008 · CA
Core B: Human Pancreas
$214,892Walter Gwang-Up Park · Stanford University · P01 · FY2024 · CA
Imaging Nuclear Receptor LRH-1 in Functional Transcriptional Assemblies
$214,886Robert J Fletterick · University Of California, San Francisco · R21 · FY2010 · DK